Thus, in obesity and obesity-related conditions, the immunomodulatory mechanisms of ghrelin have multiple points of actions and might not be restricted to the neural tissue (Figure 2). The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.